Luke Evnin insider trades: Entrada Therapeutics (TRDA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Luke reports to the SEC
and 43 more companies
Open-market buys and sales
168 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | TRDA | ↓ Sell | 86,914 | $7.08 | $616K | Indirect | Aug 31, 2026 (0d) |
| Aug 26, 2026 | TRDA | ↓ Sell | 62,714 | $7.36 | $462K | Indirect | Aug 26, 2026 (0d) |
| Jul 7, 2026 | HOWL | ↓ Sell | 143,199 | $0.31 | $45K | Indirect | Jul 8, 2026 (1d) |
| Jun 29, 2026 | HOWL | ↓ Sell | 157,084 | $0.30 | $47K | Indirect | Jun 29, 2026 (0d) |
| Jun 9, 2026 | HOWL | ↓ Sell | 76,928 | $0.37 | $28K | Indirect | Jun 10, 2026 (1d) |
| Jun 3, 2026 | HOWL | ↓ Sell | 139,803 | $0.46 | $64K | Indirect | Jun 3, 2026 (0d) |
| May 29, 2026 | HOWL | ↓ Sell | 141,106 | $0.47 | $66K | Indirect | May 29, 2026 (0d) |
| May 26, 2026 | HOWL | ↓ Sell | 191,762 | $0.45 | $87K | Indirect | May 26, 2026 (0d) |
| May 20, 2026 | HOWL | ↓ Sell | 171,049 | $0.45 | $76K | Indirect | May 20, 2026 (0d) |
| May 13, 2026 | HOWL | ↓ Sell | 44,679 | $0.54 | $24K | Indirect | May 13, 2026 (0d) |
| May 12, 2026 | HOWL | ↓ Sell | 407,574 | $0.69 | $280K | Indirect | May 12, 2026 (0d) |
| May 7, 2026 | HOWL | ↓ Sell | 100,581 | $0.64 | $64K | Indirect | May 7, 2026 (0d) |
| May 4, 2026 | HOWL | ↓ Sell | 274,619 | $0.72 | $198K | Indirect | May 4, 2026 (0d) |
| Apr 29, 2026 | HOWL | ↓ Sell | 205,911 | $0.75 | $155K | Indirect | Apr 29, 2026 (0d) |
| Jan 16, 2026 | HOWL | ↓ Sell | 38,782 | $0.54 | $21K | Indirect | Jan 20, 2026 (4d) |
| Jan 15, 2026 | HOWL | ↓ Sell | 111,227 | $0.56 | $62K | Indirect | Jan 15, 2026 (0d) |
| Jan 12, 2026 | AKTS | ↑ Buy | 1,112,777 | $18.00 | $20.0M | Indirect | Jan 14, 2026 (2d) |
| Jan 12, 2026 | HOWL | ↓ Sell | 91,374 | $0.59 | $54K | Indirect | Jan 12, 2026 (0d) |
| Jan 7, 2026 | HOWL | ↓ Sell | 71,054 | $0.65 | $46K | Indirect | Jan 7, 2026 (0d) |
| Jan 2, 2026 | HOWL | ↓ Sell | 78,377 | $0.62 | $48K | Indirect | Jan 2, 2026 (0d) |
| Dec 17, 2025 | HOWL | ↓ Sell | 48,171 | $1.08 | $52K | Indirect | Dec 17, 2025 (0d) |
| Dec 12, 2025 | HOWL | ↓ Sell | 82,971 | $1.07 | $89K | Indirect | Dec 12, 2025 (0d) |
| Dec 9, 2025 | HOWL | ↓ Sell | 95,179 | $1.00 | $95K | Indirect | Dec 9, 2025 (0d) |
| Dec 4, 2025 | HOWL | ↓ Sell | 128,185 | $0.92 | $118K | Indirect | Dec 4, 2025 (0d) |
| Dec 1, 2025 | HOWL | ↓ Sell | 91,088 | $0.96 | $88K | Indirect | Dec 1, 2025 (0d) |
| Nov 25, 2025 | HOWL | ↓ Sell | 125,576 | $0.92 | $115K | Indirect | Nov 25, 2025 (0d) |
| Nov 20, 2025 | HOWL | ↓ Sell | 102,753 | $0.92 | $95K | Indirect | Nov 20, 2025 (0d) |
| Nov 17, 2025 | HOWL | ↓ Sell | 134,553 | $0.96 | $129K | Indirect | Nov 17, 2025 (0d) |
| Nov 12, 2025 | HOWL | ↓ Sell | 137,041 | $1.13 | $155K | Indirect | Nov 12, 2025 (0d) |
| Nov 6, 2025 | HOWL | ↓ Sell | 155,885 | $1.22 | $190K | Indirect | Nov 6, 2025 (0d) |
| Nov 3, 2025 | HOWL | ↓ Sell | 189,356 | $1.33 | $251K | Indirect | Nov 3, 2025 (0d) |
| Oct 29, 2025 | HOWL | ↓ Sell | 177,145 | $1.62 | $286K | Indirect | Oct 29, 2025 (0d) |
| May 13, 2025 | ITOS | ↓ Sell | 630,191 | $8.06 | $5.1M | Indirect | May 15, 2025 (2d) |
| Mar 27, 2025 | HOWL | ↓ Sell | 2,425 | $1.05 | $3K | Indirect | Apr 30, 2025 (34d) |
| Dec 11, 2024 | TRDA | ↓ Sell | 44,722 | $20.51 | $917K | Indirect | Dec 12, 2024 (1d) |
| May 22, 2023 | TCRR | ↓ Sell | 70,170 | $1.88 | $132K | Direct | May 24, 2023 (2d) |
| Jan 5, 2022 | ITOS | ↓ Sell | 146,685 | $42.58 | $6.2M | Indirect | Jan 6, 2022 (1d) |
| Dec 7, 2021 | ITOS | ↓ Sell | 49,831 | $33.73 | $1.7M | Indirect | Dec 7, 2021 (0d) |
| Dec 2, 2021 | ITOS | ↓ Sell | 76,089 | $34.43 | $2.6M | Indirect | Dec 2, 2021 (0d) |
| Dec 2, 2021 | ITOS | ↓ Sell | 7,430 | $34.83 | $259K | See Fpotnote | Dec 2, 2021 (0d) |
| Nov 29, 2021 | ITOS | ↓ Sell | 23,045 | $35.18 | $811K | Indirect | Nov 30, 2021 (1d) |
| Nov 24, 2021 | ITOS | ↓ Sell | 77,455 | $36.61 | $2.8M | Indirect | Nov 24, 2021 (0d) |
| Nov 2, 2021 | TRDA | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Nov 4, 2021 (2d) |
| Oct 18, 2021 | ITOS | ↓ Sell | 17,099 | $27.45 | $469K | Indirect | Oct 18, 2021 (0d) |
| Oct 14, 2021 | ITOS | ↓ Sell | 56,770 | $27.21 | $1.5M | Indirect | Oct 14, 2021 (0d) |
| Oct 11, 2021 | ITOS | ↓ Sell | 51,993 | $27.23 | $1.4M | Indirect | Oct 12, 2021 (1d) |
| Oct 4, 2021 | ITOS | ↓ Sell | 27,566 | $27.05 | $746K | Indirect | Oct 5, 2021 (1d) |
| Sep 30, 2021 | ITOS | ↓ Sell | 21,506 | $27.00 | $581K | Indirect | Sep 30, 2021 (0d) |
| Sep 27, 2021 | ITOS | ↓ Sell | 53,468 | $27.76 | $1.5M | Indirect | Sep 27, 2021 (0d) |
| Sep 22, 2021 | ITOS | ↓ Sell | 33,929 | $27.50 | $933K | Indirect | Sep 23, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TRDA insiders
Open-market trades in the last 12 months
About Luke Evnin's insider trades
Luke Evnin is a 10% owner of Entrada Therapeutics (TRDA). Since Jun 20, 2005, Luke has reported 39 open-market purchases worth $112.4M and 129 sales worth $204.0M on SEC Form 4. In the last 12 months: 1 buy ($20.0M) and 29 sales ($3.6M).
12 sales (4% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include other transactions (42 filings), conversions (36 filings), grants and awards (34 filings), option exercises (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.